Norfloxacin and ursolic acid: In vitro association and postantibiotic effect against Staphylococcus aureus

Letters in Applied Microbiology

Volumn 53, Issue 2, 2011, Pages 193-197

  Filocamo, A ^a   Bisignano, C ^a   D'Arrigo, M ^a   Ginestra, G ^a   Mandalari, G ^a   Galati, E M ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Norfloxacin; Postantibiotic effect; Synergism; Ursolic acid

Indexed keywords

ANTIMICROBIAL AGENTS; CARBOXYLIC ACIDS; MICROWAVE INTEGRATED CIRCUITS;

BACTERIAL KILLING; CONCENTRATION EFFECTS; IN-VITRO; MINIMAL INHIBITORY CONCENTRATION; NORFLOXACIN; POSTANTIBIOTIC EFFECT; STAPHYLOCOCCUS AUREUS; SYNERGISM; SYNERGISTIC INTERACTION; URSOLIC ACID;

BACTERIA;

NORFLOXACIN; URSOLIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; INHIBITOR; MORTALITY; SKIN DISORDER; SYNERGISM; TERPENE;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 79960137510     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03090.x     Document Type: Article

References (19)

1. Aeschlimann, J.R., Dresser, L.D., Kaatz, G.W. and Rybak, M.J. (1999) Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 43, 335-340.
2. Clinical and Laboratory Standards Institute (2008) M100-S18. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Seventeenth Informational Supplement Clinical Laboratory Standards Institute.
3. Craig, W.A. and Gudmundsson, S. (1996) The postantibiotic effect. In Antibiotics in Laboratory Medicine, 4th edn ed. Lorian, V. pp. 296-329 Baltimore, MD: Williams & Wilkins Co.
4. Cunha, S.L.C., Silva, M.L.A., Furtado, N.A.J.C., Vinhólis, A.H.C., Martins, C.H.G., Silva-Filho, A.A. and Cunha, W.R. (2007) Antibacterial activity of triterpene acids and semi-synthetic derivatives against oral pathogens. Z Naturforsch 62, 668-672.
5. D'Arrigo, M., Ginestra, G., Mandalari, G., Furneri, P.M. and Bisignano, G. (2010) Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli. Phytomedicine 17, 317-322.
6. Fontanay, S., Grare, M., Mayer, J., Finance, C. and Duval, R.E. (2008) Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes. J Ethnopharmacol 120, 272-276.
7. Fournier, B., Zhao, X., Lu, T., Drlica, K. and Hooper, D.C. (2000) Selective Targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different pattern in quinolone-induced inhibition of DNA synthesis. Antimicrob Agents Chemother 44, 2160-2165.
8. Gottfredsson, M., Erlendsdóttir, H., Gudmundsson, A. and Gudmundsson, S. (1995) Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob Agents Chemother 39, 1314-1319.
9. Hemaiswarya, S., Kruthiventi, A.K. and Doble, M. (2008) Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15, 639-652.
10. Horiuchi, K., Shiota, S., Hatano, T., Yoshida, T., Kuroda, T. and Tsuchiya, T. (2007) Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE). Biol Pharm Bull 30, 1147-1149.
11. Ikeda, Y., Murakami, A. and Ohigashi, H. (2008) Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 52, 26-42.
12. Khodursky, A.B., Zechiedrich, E.L. and Cozzarelli, N.R. (1995) Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci USA 92, 11801-11805.
13. Löwdin, O., Odenholt, I. and Cars, O. (1993) A new method to determine the postantibiotic effects and the effects of subinhibitory antibiotic concentrations. Antimicrob Agents Chemother 37, 2200-2205.
14. Odenholt, I. (1993) The postantibiotic effect and the postantibiotic sub-MIC effect of meropenem measured with two different methods. J Antimicrob Chemother 31, 881-892.
15. Olofsson, S.K., Marcusson, L.L., Stromback, A., Hughes, D. and Cars, O. (2007) Dose-related selection of fluoroquinolone-resistant Eschericha coli. J Antimicrob Chemother 60, 795-801.
16. Piddock, L.J.V. and Wise, R. (1987) Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents. FEMS Microbiol Lett 41, 918-932.
17. Sikkema, J., de Bont, J.A.M. and Poolman, B. (1994) Interactions of cyclic hydrocarbons with biological membranes. J Biol Chem 296, 8022-8028.
18. Visalli, M.A., Jacobs, M.R. and Appelbaum, P.C. (1998) Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrob Agents Chemother 42, 953-955.
19. White, R.L., Burgess, D.S., Manduru, M. and Bosso, J.A. (1996) Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40, 1914-1918.